Research graph
References from Development of orodispersible wafer-based delayed-release omeprazole systems for pediatric compounding. Local targets link to admitted publications; unresolved targets remain external evidence.
Design and manufacturing of fixed-dose combination coated minitablets for pediatric GERD therapy
2026 · External reference
New spray congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances
10.1016/j.ejpb.2007.09.011 · 2008 · External reference
Bionanocomposites based on alginate–zein/layered double hydroxide materials as drug delivery systems
10.1039/c0jm01211d · 2010 · External reference
Hydrophobic solid lipid-based microparticles for the protection of gastric-sensitive hydrophilic active biomolecules for oral administration in the treatment of EPI
10.1016/j.ejpb.2024.114504 · 2024 · External reference
Spray congealed lipid microparticles for the local delivery of β-galactosidase to the small intestine
10.1016/j.ejpb.2018.08.014 · 2018 · External reference
Spray congealing: a versatile technology for advanced drug-delivery systems
10.4155/tde-2018-0049 · 2018 · External reference
Liquid lipids act as polymorphic modifiers of tristearin-based formulations produced by melting technologies
10.3390/pharmaceutics13071089 · 2021 · External reference
The use of polymorphic state modifiers in solid lipid microparticles: the role of structural modifications on drug release performance
10.1016/j.ejps.2023.106650 · 2024 · External reference
Solid lipid microparticles for oral delivery of catalase: focus on the protein structural integrity and gastric protection
10.1021/acs.molpharmaceut.0c00666 · 2020 · External reference
Formulation and stability study of omeprazole oral liquid suspension for pediatric patients
10.1177/0018578719844704 · 2020 · External reference
Solid lipid microparticles by spray congealing of water/oil emulsion: an effective/versatile loading strategy for a highly soluble drug
10.3390/pharmaceutics14122805 · 2022 · External reference
Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements
10.1016/j.drudis.2017.10.003 · 2018 · External reference
A mini-review on drug delivery through wafer technology: formulation and manufacturing of buccal and oral lyophilizates
10.1016/j.jare.2019.04.010 · 2019 · External reference
Orodispersible Film (ODF) platform based on maltodextrin for therapeutical applications
10.3390/pharmaceutics14102011 · 2022 · External reference
Alginate beads as a carrier for omeprazole/SBA-15 inclusion compound: a step towards the development of personalized paediatric dosage forms
10.1016/j.carbpol.2015.07.064 · 2015 · External reference
Degradation of lansoprazole and omeprazole in the aquatic environment
10.1016/j.chemosphere.2005.09.003 · 2006 · External reference
Omeprazole nanoparticles suspension: development of a stable liquid formulation with a view to pediatric administration
10.1016/j.ijpharm.2020.119818 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
10.1016/j.ejpb.2024.114483 · 2024 · External reference
A toolbox for mimicking gastrointestinal conditions in children: design and evaluation of biorelevant dissolution media for mimicking paediatric gastric- and small intestinal conditions
10.1016/j.ejpb.2023.10.011 · 2023 · External reference
Chemical stability of extemporaneously compounded omeprazole formulations: a comparison of two methods of compounding
2009 · External reference
Performance evaluation of montelukast pediatric formulations: part I—age-related in vitro conditions
10.1208/s12248-021-00661-2 · 2022 · External reference
Microparticle size control and glimepiride microencapsulation using spray congealing technology
10.1016/j.ijpharm.2009.05.011 · 2009 · External reference
Pediatric drug formulations: a review of challenges and progress
10.1542/peds.2013-3225 · 2014 · External reference
Orally disintegrating drug carriers for paediatric pharmacotherapy
10.1016/j.ejps.2023.106377 · 2023 · External reference
Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine
10.1136/ejhpharm-2013-000347 · 2014 · External reference
Children are not just small adults: the urgent need for high-quality trial evidence in children
10.1371/journal.pmed.0050172 · 2008 · External reference
Nanoparticles obtained from zein for encapsulation of mesalazine
10.3390/pharmaceutics14122830 · 2022 · External reference
Pectin/zein beads for potential colon-specific drug delivery: synthesis and in vitro evaluation
10.1080/10717540500394935 · 2006 · External reference
Assessment of age-related changes in pediatric gastrointestinal solubility
10.1007/s11095-015-1762-7 · 2016 · External reference
Oral disintegration films: applications and production methods
10.1007/s13197-022-05589-9 · 2023 · External reference
Off-label prescribing in pediatric population—literature review for 2012–2022
10.3390/pharmaceutics15122652 · 2023 · External reference
Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form
10.1016/j.ijpharm.2019.06.007 · 2019 · External reference
Application of galenic strategies for developing gastro-resistant omeprazole formulation for pediatrics
10.3390/children11080945 · 2024 · External reference
Formulation of dosage forms with proton pump inhibitors: state of the art, challenges and future perspectives
10.3390/pharmaceutics14102043 · 2022 · External reference
Drug formulations: standards and novel strategies for drug administration in pediatrics
10.1002/jcph.1138 · 2018 · External reference
Personalized medicine in pediatrics: the clinical potential of orodispersible films
10.1208/s12249-016-0515-1 · 2017 · External reference
Fine powder of lipid microparticles – spray drying process development and optimization
2021 · External reference
